Trademark: 90310251
Status Date
Monday, December 11, 2023
Filing Date
Tuesday, November 10, 2020
Published for Opposition
Tuesday, June 1, 2021
5 Medicines for stimulation of vascular and cardiovascular regeneration; pharmaceuticals for stimulation of vascular and cardiovascular regeneration using stem cells and allogenic cells; chemical and diagnostic preparations for medical purposes for treatment of vascular and cardiovascular diseases; pharmaceutical preparations for the treatment and prevention of vascular and cardiovascular diseases; chemical, biological and diagnostic reagents and prepared laboratory media for clinical or medical purposes; pharmaceutical preparations for the treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia; Biological preparations, namely, genetically modified cells for medical and therapeutic purposes; Derivatives and modulators of cultured cells, namely, conditioned media for medical use; biologics, biotherapeutics, and therapeutics, namely, extracellular vesicle-based therapeutics for the prevention and treatment of vascular and cardiovascular diseases and disorders
1 Cell culture media supplements for laboratory use, scientific and research use; chemical, biological and diagnostic reagents and prepared laboratory media for scientific or research purposes; biological preparation for use in vascular and cardiovascular cell culture media other than for medical or veterinary use; cell culture media supplement used for the production of biological therapeutics; stem cell culture reagent system comprising chemical culture nutrients, culture growth proteins and protein microarrays for the expansion of stem cells for research and manufacturing use; Biological preparations, namely, genetically modified cells for clinical and commercial use in scientific research, and for use in pharmaceutical research; Cell growth media and conditioned media for growing cells for scientific use, research use or commercial use other than for medical or veterinary purposes
42 Development of pharmaceutical preparations and medicines; medical and scientific research in the field of vascular and cardiovascular impairments; medical and scientific research in the field of allogeneic cell therapy; medical and scientific research in the field of regenerative medicine; providing medical and scientific research information in the field of regenerative medicine, vascular and cardiovascular impairments, and allogenic cell therapies; medical and scientific research in the field of treatment and prevention of critical limb ischemia, diabetic foot ulcer, peripheral artery disease, diabetic retinopathy, age-related macular degeneration, heart failure, stroke, traumatic brain injury, acute kidney injury, acute respiratory distress syndrome, bronchopulmonary dysplasia
Dec 12, 2023
Notice Of Approval Of Extension Request E-Mailed
Dec 11, 2023
Sou Extension 5 Granted
Dec 1, 2023
Sou Extension 5 Filed
Dec 11, 2023
Case Assigned To Intent To Use Paralegal
Dec 1, 2023
Sou Teas Extension Received
Jul 15, 2023
Notice Of Approval Of Extension Request E-Mailed
Jul 13, 2023
Sou Extension 4 Granted
Jul 13, 2023
Sou Extension 4 Filed
Jul 13, 2023
Sou Teas Extension Received
Jan 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 20, 2023
Sou Extension 3 Granted
Jan 20, 2023
Sou Extension 3 Filed
Jan 20, 2023
Sou Teas Extension Received
Jun 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2022
Sou Extension 2 Granted
Jun 24, 2022
Sou Extension 2 Filed
Jun 24, 2022
Sou Teas Extension Received
Jan 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2022
Sou Extension 1 Granted
Jan 3, 2022
Sou Extension 1 Filed
Jan 3, 2022
Sou Teas Extension Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 29, 2021
Approved For Pub - Principal Register
Apr 19, 2021
Assigned To Examiner
Jan 9, 2021
New Application Office Supplied Data Entered
Nov 13, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
